期刊文献+

口腔变形链球菌感受态刺激因子的蛋白合成及活性检测 被引量:6

Chemical synthesis and biological activities of competence stimulated peptide of quorum sensing system in Streptococcus mutans UA159
原文传递
导出
摘要 目的探讨口腔变形链球菌(S.mutans)密度感应系统信号蛋白的体外合成及其生物活性。方法采用化学合成法口腔S.mutans密度感应感受态刺激因子(CSP)信号蛋白,通过高效液相色谱仪纯化合成蛋白,质谱分析结构,通过扫描电镜对比观察CSP信号蛋白对S.mutans生物膜形成的影响,分析CSP信号蛋白的生物活性。结果化学合成纯化S.mutans CSP蛋白分子,加入CSP信号肽后,S.mutans生物膜呈团状密集分布,细菌之间存在厚实的黏性胞外分泌物,细菌黏连呈链团状。结论成功合成口腔S.mutans CSP信号蛋白,该蛋白肽具备促进S.mutans生物膜形成的生物活性。 Objective To synthesize and analyze the biological activities of the competence stimulated peptide (CSP) in Streptococcus mutans (S.mutans) quorum sensing system. Methods The CSP peptide derived from S.mutans UA159 comC gene N-terminal 26-46 was chemically synthesized and purified. The biological activity of CSP, which was used as a quorum-sensing signal in S.mutans biofihn formation CSP, was analyzed by scanning electron microscope (SEM). Results The CSP was accurately synthesized, and SEM confirmed the addition of chemically synthetic CSP induced the adhesion of S.mutans cells and significantly increased the biofilm formation of S.mutans. Conclusion The CSP was chemically synthesized with biological activities, which made it possible to study the mechanism of quorum sensing system in S.mutans.
出处 《中华口腔医学研究杂志(电子版)》 CAS 2012年第6期5-8,共4页 Chinese Journal of Stomatological Research(Electronic Edition)
基金 国家自然科学基金(30973320 81000432) 教育部高等学校博士学科点专项科研基金(20100171120102) 广东省高校优秀青年创新人才培育项目(育苗工程 LYM10002) 中央高校基本科研业务费专项资金(09ykpy65) 广东省医学科学技术基金(A2010197) 中大重大项目培育和新兴 交叉学科资助计划(10ykjc16)
关键词 变形链球菌 密度感应 信号肽 化学合成 Streptococcus mutans ComCDE system Signaling peptide Quorum sensing
  • 相关文献

参考文献16

  • 1Yoshida A, Kuramitsu HK. Multiple Streptococcus mutans Genes Are Involved in Biofilm Formation. Appl Environ Microbiol, 2002,68(12) : 6283-6291.
  • 2Luo P, Morrison DA. Transient association of an alternative sigma factor, ComX, with RNA polymerase during the period of competence for genetic transformation in Streptococcus pneumoniae. J Bacteriol, 2003,185 (1) : 349-358.
  • 3Senadheera D, Cvitkovitch DG. Quorum sensing and biofilm formation by Streptococcus mutans. Adv Exp Med Biol, 2008, 631 :178-188.
  • 4van der Ploeg JR. Regulation of bacteriocin production in Streptococcus mutans by the quorum-sensing system required for development of genetic competence. J Bacteriol, 2005,187(12) : 3980-3989.
  • 5Cvitkovitch DG, Li YH, Ellen RP. Quorum sensing and biofilm formation in Streptococcal infections. J Clin Invest, 2003,112 (11):1626-1632.
  • 6Zhang K, Ou M, Wang W, et al. Effects of quorum sensing on cell viability in Streptococcus mutans biofilm formation. Binchem Biophys Res Commun, 2009,379(4):933-938.
  • 7Lee MS, Morrison DA. Identification of a new regulator in Streptococcus pneumoniae linking quorum sensing to competence for genetic transformation. J Bacteriol, 1999,181 (16) :5004-5016.
  • 8Kroes I, Lepp PW, Relman DA. Bacterial diversity within the human subgingival crevice. Proc Natl Acad Sci U S A, 1999, 96(25) : 14547-14552.
  • 9Ajdic D, McShan WM, McLaughlin RE, et al. Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen. Proc Natl Acad Sci USA, 2002,99(22):14434-14439.
  • 10Wen ZT, Burne RA. Functional genomics approach to identifying genes required for biofilm development by Streptococcus mutans. Appl Environ Microbiol, 2002,68 (3) : 1196-1203.

同被引文献93

  • 1曾定芬,江华,李晓霞,阳静,范玉霞.口腔癌术后不同口腔护理方法比较[J].中华临床感染病杂志,2013,6(4):230-233. 被引量:9
  • 2Stokman MA, Spijkervet FKL,Schouten HM, et al. Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositia: result of meta-analyses . Journal of Dental Research,2006,85:690- 700.
  • 3Wu HG, Song SY, Kim YS, et al. Therapeutic effect of recombinant human epidermal growth factor ( RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo- controlled prospective phase 2 multiinstitutional clinical trial. Cancer, 2009, 115: 3699-3708.
  • 4Fukazawa M, Kawaguchi H, Shigematsu H, et al. High incideneerate of oral muco- sitis in breast cancer patients receiving an- thracycline-based chemotherapy (FEC 100)[J]. Cre To Kaonk'u Ryoho, 2012, 39(3) : 395-398.
  • 5Clarkson JE, Worthington HV, Eden OB. Interventions for preventing oral mucosi tis for patients with cancer receiving treat ment[J]. Cochrane Database Syst Rev, 2003,34(3) : 1231-1237.
  • 6Tsuyuki S, Kawaguchi K, Kawata Y, et al.Usefulness of antimycofic agents (ilraco- nazole) in chemotherapy-induced mucosi- tis of breast cancer patients[J]. Gan To Kagaku Ryoho, 2012, 39(9) : 1369-1373.
  • 7Nishimura N, Nakano K, Ueda K, et al. Prospective evaluation of incidence and severity of oral mucositis induced by con- ventional chemotherapy in solid tumors and malignant lymphomas [J]. Support Care Cancer, 2012, 20(9) : 2053-2059.
  • 8Cheng KK, Lee V, Li CH, et al. Oral mucositis in pediatric and adolescent pati- ents undergoing chemotherapy: the im- pact of symptoms on quality of life[J]. Sutroort Care Cancer. 2012. 20(10): 2335-2342.
  • 9Yen SH, Wang LW, Lin YH, et al. Phe- nylbutyrate mouthwash mitigates oral mu- cositis during radiotherapy or chemora-diotherapy in patients with head-and-neck cancer[J]. Int J Radiat Oncol Biol Phys, 2012, 82(4) : 1463-1470.
  • 10Elting LS,Cooksley C,Chambers M,et al.The burdens of cancer therapy.Clinical and economic outcomes of chemotherapy-induced mucositis[J].Cancer,2003,98(7):1531-1539.

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部